Keyphrases
Clinical Trials
100%
Placebo
100%
Meta-analysis
100%
Systematic Meta-analysis
100%
Placebo Response Rate
100%
Perianal Crohn's Disease
100%
Response Rate
54%
Randomized Controlled Trial
45%
Fistula Closure
36%
Confidence Interval
27%
Pharmacologic Agents
27%
Embase
18%
Fistula
18%
Disease Progression
9%
Patient Characteristics
9%
AIMS™
9%
Short Intervals
9%
Duration of Therapy
9%
Response Predictors
9%
Placebo Groups
9%
MEDLINE
9%
Partial Response
9%
Random Effects Model
9%
Cochrane Central Register of Controlled Trials
9%
Induction Period
9%
Concomitant Medications
9%
Intention-to-treat Analysis
9%
Trial Characteristics
9%
Partial Closure
9%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Placebo
100%
Crohn's Disease
100%
Fistula
46%
Randomized Controlled Trial
38%
Random Effects Model
7%
Disease Exacerbation
7%